A number of special interest groups within ESCMID have opened their doors to corporate membership. The ESGVH executive has also decided to do this, as a way of interesting and involving diagnostic and therapeutic companies in our activities. We believe that progress in the diagnosis and management of viral hepatitis requires collaborative effort and input from both physicians and industry. The ESCMID executive recently released updated "ESCMID Operating Procedures for Study Groups" guiding all Study Group activities - including corporate membership - and subsequently, we have invited a number of companies to join ESGVH. We hope that this will encourage them to organize hepatitis-related symposia at ECCMID, thereby increasing the hepatitis content of those annual meetings. If ESGVH members know of companies that would be interested in joining us, please let a member of the Executive Committee know so that we can send out our standard letter of invitation to them. The standard ESGVH fee for corporate membership is 1'000 Euros, so this also represents a way in which ESGVH can accumulate modest financial support to fund and extend our activities.